---
category: news
title: "NEC: harnessing artificial intelligence-powered drug development to provide tailored medicines"
excerpt: "Individualized cancer therapies represent the next step for cancer immunotherapy. NEC Corporation has developed cutting-edge artificial intelligence to predict patient-specific neoantigens to turn this promise into reality and extend the approach to infectious diseases."
publishedDateTime: 2022-04-11T16:38:00Z
originalUrl: "https://www.nature.com/articles/d43747-022-00109-2"
webUrl: "https://www.nature.com/articles/d43747-022-00109-2"
type: article
quality: 42
heat: 42
published: false

provider:
  name: Nature
  domain: nature.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://media.nature.com/lw1024/magazine-assets/d43747-022-00109-2/d43747-022-00109-2_20292782.png"
    width: 1024
    height: 524
    isCached: true

secured: "hM1BUiiQ8jGPixCqc4YhuhN2szV7oxFbGZrXewo3K3SdVZLbmm9vTdJqGipLciC1ma77gYWeisdIrm1hstYcV9HZowNKwrkXRVqdBpABCPxxrC3xGAecVFds0peMyO4BXTxzq0yVG1n6zEbJYTs/PX2mzEfBN58T3r5axWENyXswb2FoSF9uzb0EYy+ZOZFGJG7/hP85cVK9cJhzpX9M7MCdzIAmePhi4Q+yT/yRpm7JJaqUB4c7dmdD1NeqX2IDY3lSVPZtOwGbPEUCvlglEQVoHSgpnXTm/0XoE7CDltCc3surdWDgkMS0iSwRaCF928XzDg3HXShOYCBzsIHJunANxThkXsAYc/K04XPh/KU=;9hAmbcL0C+hxZp5gKyhiqQ=="
---

